Type 2 Diabetes Clinical Trial
Official title:
An Online, Compassion Intervention to Improve Shame, Self-criticism, and Physical Wellbeing in Adults With Type 1 and Type 2 Diabetes Mellitus (T1DM; T2DM)
| Verified date | March 2024 |
| Source | Canterbury Christ Church University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The goal of this research study is to evaluate a programme that is based on Compassionate Mind Training (CMT) over four-weeks. The programme intends to share information and strategies to reduce diabetes distress, self-criticism, and shame, and improve physical health in people who have Type 1 and Type 2 Diabetes Mellitus.
| Status | Completed |
| Enrollment | 56 |
| Est. completion date | December 12, 2023 |
| Est. primary completion date | October 31, 2023 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Resident in the United Kingdom; - Clinician diagnosed Type 1 Diabetes Mellitus or Type 2 Diabetes Mellitus; - Self-managing condition; - Diabetes diagnosed over a year ago. Exclusion Criteria: - Diagnosis of Gestational Diabetes or Pre-Diabetes. - Current severe mental health condition; - Currently self-harming or suicidal; - Currently engaging in psychological therapy. |
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | Salomons Institute for Applied Psychology, Canterbury Christ Church University, 1 Meadow Road | Tunbridge Wells |
| Lead Sponsor | Collaborator |
|---|---|
| Canterbury Christ Church University |
United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in Diabetes Distress Scale (DDS) scores from baseline (week 0) to post-intervention (week 4). | The DDS is a 17-item measure of problems and hassles related to diabetes.
The DDS establishes a total mean score and a mean score for its four sub-scales. Scores will range from 1 to 6. Mean scores of 3 or above is considered distress worthy of clinical attention. |
Post-intervention (week 4) | |
| Secondary | Change in the total score on the External and Internal Shame Scale (EISS) from baseline (week 0) to post-intervention (week 4). | The EISS is an eight-item scale measuring external and internal dimensions of shame.
Higher scores indicate higher levels of shame and a total score varies between 8 and 40. |
Post-intervention (week 4) | |
| Secondary | Change in Forms of Self-Criticising/Attacking and Self-Reassuring Scale (FSCRS) scores from baseline (week 0) to post-intervention (week 4). | The FSCRS is a 22-item scale with statements measuring inadequate self, hated self and reassured self.
Scores will range from 0 to 88. |
Post-intervention (week 4) | |
| Secondary | Change in Fears of Compassion Scale (FCS) scores from baseline (week 0) to post-intervention (week 4). | The FCS is a 15-item measure of fear of compassion towards self.
Scores will range from 0 to 60. Higher scores indicate greater fear of compassion. |
Post-intervention (week 4) | |
| Secondary | Change in Warwick-Edinburgh Mental Wellbeing Scales (WEMWBS) scores at baseline (week 0) and post-intervention (week 4). | 14-item measure assessing mental wellbeing in the non-clinical sample. Scores on the WEMWBS will range from 14 to 70. Higher scores indicate greater positive mental wellbeing. | Post-intervention (week 4) | |
| Secondary | Change in Compassionate Engagement and Action Scale (CEAS) scores at baseline (week 0) and post-intervention (week 4). | The CEAS is a 13-item measure of compassionate engagement and action.
The engagement sub-scale will establish a score between 6 and 60. The action sub-scale will establish a score between 4 and 40. |
Post-intervention (week 4) | |
| Secondary | Change in HbA1c from baseline (week 0) to follow-up (week 8). | Participants will be asked to self-report a blood glucose (HbA1c) level taken by a healthcare provider in the past three to six months at baseline and at one-month post-intervention.
Higher HbA1c levels indicate poorer diabetes control. |
Follow-up (week 8) | |
| Secondary | Change in Warwick-Edinburgh Mental Wellbeing Scales (WEMWBS) scores at baseline (week 0) and follow-up (week 8). | Please see description above. | Follow-up (week 8) | |
| Secondary | Change in the total score on the External and Internal Shame Scale (EISS) from baseline (week 0) to follow-up (week 8). | Please see description above. | Follow-up (week 8) | |
| Secondary | Change in Forms of Self-Criticising/Attacking and Self-Reassuring Scale (FSCRS) scores from baseline (week 0) to follow-up (week 8). | Please see description above. | Follow-up (week 8) | |
| Secondary | Change in Diabetes Distress Scale (DDS) scores from baseline (week 0) to follow-up (week 8). | Please see description above. | Follow-up (week 8) | |
| Secondary | Change in Fears of Compassion Scale (FCS) scores from baseline (week 0) to follow-up (week 8) | Please see description above. | Follow-up (week 8) | |
| Secondary | Change in Compassionate Engagement and Action Scale (CEAS) scores at baseline (week 0) to follow-up (week 8). | Please see description above. | Follow-up (week 8) |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |